Public Company News

Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial

SYDNEY, Nov. 7, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that 50 patients have no...

2023-11-07 21:58 2246

WiMi Developed a Liquid Crystal on Silicon (LCoS) Technology Solution

BEIJING, Nov. 7, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it has developed a liquid crystal on silicon (LCoS) technology solution that will revolutionize aug...

2023-11-07 21:00 2469

Lixiang Education Announces Receipt of Nasdaq Staff Determination Letter and Intent to Request Hearing

LISHUI, China, Nov. 7, 2023 /PRNewswire/ -- Lixiang Education Holding Co., Ltd. (the "Company" or NASDAQ: LXEH), a prestigious private education service provider inChina, today announced that it received a letter dated November 2, 2023 from the Staff of the Listing Qualifications Department of th...

2023-11-07 21:00 3913

Hitek Global Inc. Announces First Half of Fiscal Year 2023 Financial Results

XIAMEN, China, Nov. 7, 2023 /PRNewswire/ -- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"), aChina-based information technology consulting and solutions service provider, today announced its unaudited financial results for the six months endedJune 30, 2023. Ms. Xiaoyang Huang, Chief Executive ...

2023-11-07 21:00 3998

Kexing Biopharm Attended CPHI Worldwide 2023

SHENZHEN, China, Nov. 7, 2023 /PRNewswire/ -- Recently, CPHI Worldwide 2023 was successfully held inBarcelona, Spain. Kexing Biopharm exhibited more than ten kinds of high-quality medical products in the fields of tumor, autoimmune, anti-virus, etc., including Infliximab, Adalimumab, Bevacizumab,...

2023-11-07 20:09 2374

Zepp Health Corporation to Report Third Quarter 2023 Financial Results on November 20, 2023

Earnings Call Scheduled for 7:30 a.m. ET on November 20, 2023 BEIJING, Nov. 7, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report ...

2023-11-07 20:00 2354

Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC)

HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind, multicenter, phase III clinical study evaluating PD-1/CTLA-4 bispecific antibody, cadonilimab (开坦尼®) in combination with capecitabine plus...

2023-11-07 20:00 2649

Lufax to Announce Third Quarter 2023 Financial Results on November 13, 2023

SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU), a leading financial services enabler for small business owners inChina, today announced that it plans to release its third quarter 2023 financial results after the market closes onMonday, November 13, ...

2023-11-07 19:00 3007

Vipshop to Announce Third Quarter 2023 Financial Results on November 14, 2023

GUANGZHOU, China, Nov. 7, 2023 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), today announced that it plans to release its third quarter 2023 financial results onTuesday, November 14, 2023, before the US m...

2023-11-07 18:00 2598

Full Truck Alliance Co. Ltd. to Announce Third Quarter 2023 Financial Results on Monday, November 20, 2023

Earnings Call Scheduled for 7:00 A.M. U.S. ET on November 20, 2023  GUIYANG, China, Nov. 7, 2023 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced that it will release its third quarter 2023 unaudited financial ...

2023-11-07 16:00 3202

First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science

* Creating world-class innovation by redefining how international standards are established with eco-friendly bio materials and a system. * Patent registration for one-stop system from procurement of raw materials and golden time orders from all over the world to search for optimal routes for ...

2023-11-07 15:47 2785

Tuniu to Report Third Quarter 2023 Financial Results on November 21, 2023

NANJING, China, Nov. 7, 2023 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it plans to release its unaudited financial results for the third quarter endedSeptember 30, 2023, before the market opens...

2023-11-07 14:00 2361

87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting

SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that two major clinical updates of its CSF-1R inhibitor pimicotinib(ABSK021)were presented at the 2023 Connective Tissue Oncology Society Annual Meeting, which is held inIreland from...

2023-11-07 12:31 2527

Yatsen Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

GUANGZHOU, China, Nov. 6, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leadingChina-based beauty group, today announced that, it has received a letter from the New York Stock Exchange (the "NYSE") datedNovember 2, 2023, notifying Yatsen that it is below c...

2023-11-07 06:00 2975

GV to Hold Annual Shareholder Meeting on December 11, 2023

TORONTO, Nov. 6, 2023 /PRNewswire/ -- Visionary Education Technology Holdings Group Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, today announced that it will hold an annual shareholder meeting of t...

2023-11-07 05:30 2980

Moomoo Announces Collaboration with Cboe to Offer Index Options, Hosts Event with VIPs on Nov.16

PALO ALTO, Calif., Nov. 6, 2023 /PRNewswire/ -- The intuitive investment and trading platform moomoo, today announced it is collaborating with theChicago Board of Options Exchange (Cboe) Global Markets to offer index options products to moomoo customers in the U.S. The ...

2023-11-06 22:00 3540

Hesai's Lidars Get Top Marks for Data Security

PALO ALTO, Calif., Nov. 6, 2023 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in automotive lidar solutions, announced today that its two flagship products -- Pandar128 robotaxi lidar and AT128 ADAS lidar for passenger cars – which are sold globally, including in the U.S., ha...

2023-11-06 21:30 2744

WiMi Developed a Motor Imagery Brain-computer Interface Based on Multi-source Signal Processing

BEIJING, Nov. 6, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a motor imagery brain-computer interface (MI-BCI) based on multi-source signal processing has been ...

2023-11-06 21:00 2205

Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

* Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer ...

2023-11-06 21:00 2447

I-Mab Announces Participation at Jefferies and Piper Conferences in November

ROCKVILLE, Md. and SHANGHAI, China, Nov. 6, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies...

2023-11-06 21:00 2139
1 ... 376377378379380381382 ... 766